3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
21
Terminated
6
Unknown
4
Withdrawn
1
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Sarcoma
7
Lymphoma, Large B-Cell, Diffuse
6
Osteosarcoma
3
Lymphoma, B-Cell
3
Sarcoma, Ewing
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Penile Neoplasms
2
Neurofibrosarcoma
2
Liposarcoma
2
Hemangiosarcoma
2
Fibrosarcoma
2
Burkitt Lymphoma
2
Wilms Tumor
1
Vascular Neoplasms
1
Teratoma
1
Solitary Fibrous Tumors
1
Smooth Muscle Tumor
1
Sarcoma, Synovial
1
Sarcoma, Endometrial Stromal
1
Sarcoma, Clear Cell
1
Rhabdomyosarcoma
1
Recurrence
1
Prostatic Neoplasms
1
Pleuropulmonary blastoma
1
Neuroblastoma
1
Nerve Sheath Neoplasms
1
Neoplasms, Adipose Tissue
1
Neoplasm Metastasis
1
Myoepithelioma
1
Lymphoma, T-Cell, Peripheral
1
Interventions
Cyclophosphamide
29
fludarabine
19
Rituximab
15
fludarabine phosphate
12
Specimen Handling
8
obinutuzumab
7
Immunotherapy, Adoptive
7
Lenalidomide
6
Etoposide
6
pirtobrutinib
5
ibrutinib
5
glofitamab
5
axicabtagene ciloleucel
5
Whole-Body Irradiation
5
Mycophenolic Acid
5
venetoclax
4
polatuzumab vedotin
4
Prednisone
4
Melphalan
4
Granulocyte Colony-Stimulating Factor
4
Doxorubicin
4
Blood Component Removal
4
Biopsy
4
pembrolizumab
3
daratumumab
3
X-Rays
3
Vincristine
3
Stem Cell Transplantation
3
Interleukin-2
3
Injections
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Lymphoma, Non-Hodgkin
×
Ifosfamide
×
Clear all
NCT02393157
2025-08-08
O-ICE
New York Medical College
Phase 2
Recruiting
25 enrolled